Peri-transplant use of immune checkpoint inhibitors in hepatocellular carcinoma: a transplant oncology perspective on safety, timing, post-transplant management, and future directions - Top-Institutions - MDSpire

Peri-transplant use of immune checkpoint inhibitors in hepatocellular carcinoma: a transplant oncology perspective on safety, timing, post-transplant management, and future directions

  • By

  • Maen Abdelrahim

  • Abdullah Esmail

  • Bandar Al-Judaibi

  • Ola Khorshid

  • Bhoori Sherrie

  • Vincenzo Mazzaferro

  • May 28, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, CA

    Key Differentiators

    • Hepatology
    • Oncology

  • #2

    Roswell Park Comprehensive Cancer Center
    Roswell Park Comprehensive Cancer Center

    Buffalo, NY

    Key Differentiators

    • Hematology
    • Oncology

Original Source(s)

Peri-transplant use of immune checkpoint inhibitors in hepatocellular carcinoma: a transplant oncology perspective on safety, timing, post-transplant management, and future directions

  • by Maen Abdelrahim, Abdullah Esmail, Bandar Al-Judaibi, Ola Khorshid, Bhoori Sherrie, Vincenzo Mazzaferro

  • May 28, 2026

Related Content

MRI perfusion in evaluating ovarian masses: diagnostic performance of wash out rate

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications